Your browser doesn't support javascript.
loading
p53 as a target for anti-cancer drug development.
Bouchet, Benjamin Pierre; Caron de Fromentel, Claude; Puisieux, Alain; Galmarini, Carlos María.
Affiliation
  • Bouchet BP; INSERM U590, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cedex 08, France. bouchetb@lyon.fnclcc.fr
Crit Rev Oncol Hematol ; 58(3): 190-207, 2006 Jun.
Article in En | MEDLINE | ID: mdl-16690321
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Adenoviridae / Tumor Suppressor Protein p53 / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2006 Document type: Article Affiliation country: Francia Country of publication: Países Bajos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Adenoviridae / Tumor Suppressor Protein p53 / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2006 Document type: Article Affiliation country: Francia Country of publication: Países Bajos